X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (509642) 509642
Newsletter (63384) 63384
Newspaper Article (54844) 54844
Publication (40491) 40491
Book Chapter (3924) 3924
Magazine Article (3166) 3166
Book Review (2884) 2884
Web Resource (2712) 2712
Trade Publication Article (2399) 2399
Conference Proceeding (2344) 2344
Dissertation (2067) 2067
Book / eBook (718) 718
Government Document (341) 341
Report (216) 216
Reference (197) 197
Transcript (170) 170
Data Set (80) 80
Journal / eJournal (42) 42
Streaming Video (33) 33
Paper (32) 32
Archival Material (8) 8
Presentation (8) 8
Standard (7) 7
Video Recording (6) 6
Library Holding (2) 2
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (251241) 251241
insulin (236743) 236743
male (173686) 173686
animals (170113) 170113
index medicus (155331) 155331
female (151463) 151463
insulin resistance (139995) 139995
diabetes (132604) 132604
endocrinology & metabolism (97709) 97709
adult (88265) 88265
glucose (87040) 87040
middle aged (76681) 76681
research (75309) 75309
rats (73987) 73987
obesity (72933) 72933
insulin-resistance (67511) 67511
mice (59383) 59383
insulin - blood (54794) 54794
type 2 diabetes (50332) 50332
insulin - metabolism (49296) 49296
risk factors (46407) 46407
blood glucose - metabolism (44891) 44891
aged (43238) 43238
metabolism (40464) 40464
biochemistry & molecular biology (38913) 38913
diabetes mellitus (38702) 38702
physiological aspects (38606) 38606
analysis (35247) 35247
insulin - pharmacology (34400) 34400
proteins (32493) 32493
metabolic syndrome (30698) 30698
adolescent (28823) 28823
expression (28171) 28171
health aspects (28072) 28072
dextrose (27750) 27750
body mass index (27572) 27572
blood glucose - analysis (26495) 26495
cell biology (26326) 26326
insulin secretion (26228) 26228
glucose - metabolism (25436) 25436
physiology (25236) 25236
inflammation (24639) 24639
medical research (24593) 24593
reports (23946) 23946
diabetes therapy (23763) 23763
time factors (23013) 23013
nutrition & dietetics (22441) 22441
insulin - therapeutic use (22398) 22398
gene expression (22151) 22151
diet (22058) 22058
hyperglycemia (21998) 21998
care and treatment (21482) 21482
pharmacology & pharmacy (21171) 21171
rodents (21051) 21051
pregnancy (20891) 20891
glucose metabolism (20705) 20705
child (20626) 20626
glucose tolerance test (20620) 20620
cells, cultured (20149) 20149
risk (20060) 20060
disease (19798) 19798
oxidative stress (19785) 19785
article (19612) 19612
medicine (19254) 19254
medicine, experimental (19146) 19146
phosphorylation (18914) 18914
insulin - administration & dosage (18478) 18478
hypoglycemic agents - therapeutic use (18066) 18066
liver (18018) 18018
research article (17954) 17954
liver - metabolism (17863) 17863
signal transduction (17742) 17742
studies (17619) 17619
body weight (17618) 17618
hypertension (17592) 17592
mellitus (17571) 17571
medicine, general & internal (17557) 17557
medicine, research & experimental (17324) 17324
insulin sensitivity (16871) 16871
diabetes mellitus, type 2 - drug therapy (16391) 16391
peptides (16090) 16090
medicine & public health (16046) 16046
internal medicine (15913) 15913
gene-expression (15901) 15901
prevalence (15469) 15469
adipose-tissue (15334) 15334
secretion (15194) 15194
multidisciplinary sciences (15003) 15003
exercise (14869) 14869
kinetics (14789) 14789
genetic aspects (14674) 14674
lipids (14607) 14607
insulin-like growth factor i - metabolism (14575) 14575
cells (14559) 14559
resistance (14306) 14306
hypoglycemia (14302) 14302
rats, wistar (14186) 14186
insulin resistance - physiology (14178) 14178
diabetes mellitus, type 2 - blood (14168) 14168
type 1 diabetes (14166) 14166
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (340) 340
Online Resources - Online (276) 276
Collection Dvlpm't (Acquisitions) - Vendor file (55) 55
University Archives - Archives (46) 46
Thomas Fisher Rare Book - Rare Book (36) 36
Gerstein Science - Periodical Stacks (28) 28
UofT at Mississauga - Stacks (22) 22
Gerstein Science - Theses (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
Robarts - Stacks (8) 8
UTL at Downsview - May be requested (8) 8
Baycrest Hospital - Stacks (7) 7
Markham Stouffville Hospital - Stacks (7) 7
Victoria University E.J. Pratt - Stacks (6) 6
Media Commons - Audio Visual (5) 5
Trinity College (John W Graham) - Stacks (5) 5
University College (Laidlaw) - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
West Park Healthcare Centre - Stacks (5) 5
Baycrest Hospital - Wellness Library (4) 4
Gerstein Science - Bindery (4) 4
Gerstein Science - Circulation Desk (4) 4
Scarborough Hospital - Birchmount (4) 4
Scarborough Hospital - General (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
St. Michael's Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Dentistry (Harry R Abbott) - Stacks (3) 3
Media Commons - Microtexts (3) 3
OISE - Curriculum Resources (3) 3
Scarborough Hospital - Online (3) 3
Women's College Hospital - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Faculty of Information - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
Toronto East General Hospital - Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
Victoria University E.J. Pratt - Canadiana (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Bridgepoint Health - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Engineering & Comp. Sci. - Material is damaged (1) 1
Gerstein Science - Library use only (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
Media Commons - Archives: 4 days to retrieve (1) 1
Media Commons - Library or classroom use (1) 1
OISE - Theses (1) 1
Physics - Theses (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - Archives (1) 1
St. Michael's Hospital - 2nd Floor (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Periodical Stacks (1) 1
St. Michael's Hospital - Storage (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Not Returned (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (608250) 608250
German (7474) 7474
French (6204) 6204
Japanese (4878) 4878
Russian (4284) 4284
Chinese (3180) 3180
Spanish (1891) 1891
Polish (1698) 1698
Korean (1215) 1215
Czech (838) 838
Italian (763) 763
Portuguese (521) 521
Hungarian (447) 447
Swedish (309) 309
Danish (265) 265
Slovak (190) 190
Persian (159) 159
Ukrainian (150) 150
Bulgarian (144) 144
Turkish (137) 137
Finnish (134) 134
Norwegian (128) 128
Dutch (127) 127
Serbian (94) 94
Hebrew (72) 72
Croatian (66) 66
Romanian (43) 43
Arabic (32) 32
Indonesian (20) 20
Lithuanian (20) 20
Slovenian (18) 18
Icelandic (12) 12
Bosnian (9) 9
Urdu (9) 9
Afrikaans (6) 6
Greek (5) 5
Chamorro (3) 3
Estonian (3) 3
Hindi (3) 3
Samoan (3) 3
Catalan (2) 2
Vietnamese (2) 2
Azerbaijani (1) 1
Belarusian (1) 1
Georgian (1) 1
Lao (1) 1
Latvian (1) 1
Tonga (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 7/2012, Volume 72, Issue 11, pp. 1495 - 1520
Biphasic insulin aspart 30 (BIAsp 30) includes 30% soluble rapid-acting insulin aspart (IAsp) along with an intermediate-acting 70% protaminated IAsp that... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Glimepiride | Hypoglycaemia | Pioglitazone | Insulin-aspartinsulin-protamine-aspart | Sitagliptin | Blood-glucose | Exenatide | Insulin-glulisine | Insulin-neutral-protamine-lisproinsulin- lispro | Sulfonylureas | Rosiglitazone | Diabetes-mellitus | Metformin | Glibenclamide | Insulin-detemir | Insulin-glargine | Thiazolidinediones | MULTIPLE DAILY INJECTIONS | COST-EFFECTIVENESS | IMPROVES GLYCEMIC CONTROL | BASAL INSULIN | MONOMERIC INSULINS | HUMAN PREMIX INSULIN | TYPE-2 DIABETES PATIENTS | TWICE-DAILY INJECTIONS | PHARMACOLOGY & PHARMACY | OPEN-LABEL | TOXICOLOGY | SUBGROUP ANALYSIS | Hypoglycemic Agents - therapeutic use | Insulin Aspart - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Biphasic Insulins - adverse effects | Humans | Insulin Aspart - pharmacokinetics | Insulin, Isophane - pharmacokinetics | Biphasic Insulins - pharmacokinetics | Hypoglycemic Agents - pharmacology | Biphasic Insulins - pharmacology | Insulin, Isophane - therapeutic use | Animals | Biphasic Insulins - therapeutic use | Insulin, Isophane - adverse effects | Insulin Aspart - pharmacology | Insulin, Isophane - pharmacology | Hypoglycemic Agents - adverse effects | Insulin Aspart - adverse effects | Pharmaceutical research | Insulin aspart | Clinical trials | Product development | Research | Pharmaceutical industry | Testing | Review
Journal Article
2005, Advances in experimental medicine and biology, ISBN 9780387251196, Volume 567, 421
Insulin-like growth factor (IGF)-I is a widely expressed growth factor with diverse effects on many tissues throughout development and in adult life. The... 
Somatotropin | Somatomedins | Insulin-Like Growth Factor II | Peptides | Growth Hormone | Somatomedin | Insulin-Like Growth Factor I | Neurology | Maternal and Child Health | Diabetes | Medicine & Public Health | Endocrinology
Book
Diabetic Medicine, ISSN 0742-3071, 04/2016, Volume 33, Issue 4, pp. 471 - 477
Aims To assess resource utilization associated with severe hypoglycaemia across three insulin regimens in a large phase 3a clinical programme involving people... 
GLYCEMIC CONTROL | 26-WEEK | GLARGINE | NAIVE PATIENTS | ENDOCRINOLOGY & METABOLISM | NON-INFERIORITY TRIAL | OPEN-LABEL | TO-TARGET TRIAL | BASAL-BOLUS TREATMENT | TYPE-2 | DEGLUDEC/INSULIN ASPART | Hypoglycemia - therapy | Hypoglycemic Agents - economics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Insulin Detemir - therapeutic use | Insulin Detemir - economics | Clinical Trials, Phase III as Topic | Hypoglycemic Agents - administration & dosage | Hypoglycemic Agents - therapeutic use | Sitagliptin Phosphate - administration & dosage | Costs and Cost Analysis | Administration, Oral | Drug Therapy, Combination - economics | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Insulin Aspart - economics | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Insulin, Long-Acting - therapeutic use | Hypoglycemic Agents - adverse effects | Insulin Aspart - adverse effects | Cohort Studies | Insulin Aspart - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Diabetes Mellitus, Type 2 - economics | Insulin, Long-Acting - economics | Dipeptidyl-Peptidase IV Inhibitors - economics | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Insulin Aspart - administration & dosage | Insulin Detemir - administration & dosage | Insulin Detemir - adverse effects | Hypoglycemia - physiopathology | Adult | Hypoglycemia - economics | Hypoglycemia - chemically induced | Severity of Illness Index | Insulin Glargine - adverse effects | Drug Administration Schedule | Insulin Glargine - economics | Insulin Glargine - therapeutic use | Sitagliptin Phosphate - economics | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | Health Care Costs | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Sitagliptin Phosphate - adverse effects | Type 2 diabetes | Adults | Type 1 diabetes | Insulin | Analysis | Emergency medical care | Diabetes | Hypoglycemia | Complications | Research
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 12/2015, Volume 17, Issue 12, pp. 1133 - 1141
Aim To test the hypothesis that a ‘basal plus’ regimenadding once‐daily main‐meal fast‐acting insulin to basal insulin once dailywould be non‐inferior to... 
clinical trial | type 2 diabetes | insulin therapy | phase IV | Type 2 diabetes | Clinical trial | Insulin therapy | Phase IV | METFORMIN | MANAGEMENT | EUROQOL | ANALOG | TO-TARGET TRIAL | MELLITUS | TREATMENT SATISFACTION QUESTIONNAIRE | PREMIXED INSULIN | ORAL-THERAPY | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | Glycated Hemoglobin A - analysis | Insulin Aspart - therapeutic use | Hypoglycemia - epidemiology | Biphasic Insulins - adverse effects | Humans | Middle Aged | Male | Patient Dropouts | Incidence | Hypoglycemia - prevention & control | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Insulin Aspart - administration & dosage | Hypoglycemic Agents - administration & dosage | Female | Insulin - analogs & derivatives | Hypoglycemia - chemically induced | Hypoglycemic Agents - therapeutic use | Insulin, Isophane - administration & dosage | Hyperglycemia - prevention & control | Insulin Glargine - adverse effects | Drug Administration Schedule | Insulin Glargine - therapeutic use | Insulin - administration & dosage | Australia - epidemiology | Diabetes Mellitus, Type 2 - blood | Insulin, Isophane - therapeutic use | Biphasic Insulins - therapeutic use | Insulin, Isophane - adverse effects | Intention to Treat Analysis | Blood Glucose Self-Monitoring | Quality of Life | Aged | Biphasic Insulins - administration & dosage | Hyperglycemia - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin Aspart - adverse effects | United Kingdom - epidemiology | Drug Combinations | Insulin - therapeutic use | Hockey | Analysis | Clinical trials | Hemoglobin | Adults | Glucose | Insulin | Dextrose | Hyperglycemia | Diabetes | Optimization | Questionnaires
Journal Article
Journal Article
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 01/2016, Volume 32, Issue 1, pp. 21 - 39
Summary The level of glycaemic control necessary to achieve optimal short‐term and long‐term outcomes in subjects with type 1 diabetes mellitus (T1DM)... 
continuous subcutaneous insulin infusion | diabetes mellitus | rapid‐acting insulin analogue | pharmacoeconomics | pregnancy | paediatric | Pregnancy | Rapid-acting insulin analogue | Pharmacoeconomics | Paediatric | Diabetes mellitus | Continuous subcutaneous insulin infusion | MULTIPLE DAILY INJECTIONS | GLYCEMIC CONTROL | ARTIFICIAL PANCREAS | SEVERE HYPOGLYCEMIA | AUGMENTED PUMP THERAPY | RANDOMIZED CONTROLLED-TRIAL | METABOLIC-CONTROL | CLOSED-LOOP CONTROL | rapid-acting insulin analogue | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | BLOOD-GLUCOSE CONTROL | Insulin, Short-Acting - adverse effects | Insulin, Short-Acting - economics | Hypoglycemic Agents - economics | Insulin, Short-Acting - administration & dosage | Humans | Insulins - economics | Hypoglycemia - prevention & control | Hypoglycemic Agents - administration & dosage | Computer Security | Insulin Infusion Systems - economics | Hypoglycemia - chemically induced | Precision Medicine | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Insulins - administration & dosage | Europe | Insulin Infusion Systems - adverse effects | Evidence-Based Medicine | Insulin Infusion Systems - trends | Diabetes Mellitus, Type 1 - drug therapy | Infusions, Subcutaneous | Monitoring, Ambulatory | Health Care Costs | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Quality of Life | Insulins - therapeutic use | Hypoglycemic Agents - adverse effects | Insulins - adverse effects | Insulin, Short-Acting - therapeutic use | Insulin | Diabetes | Hyperglycemia | Patient satisfaction | Quality of life | Life Sciences | Human health and pathology | Endocrinology and metabolism | Review
Journal Article
Clinical Epigenetics, ISSN 1868-7075, 01/2016, Volume 8, Issue 1, p. 11
Background: Insulin-like growth factors 1 and 2 (IGF1 and IGF2) and their binding proteins (IGFBPs) are expressed in the placenta and known to regulate fetal... 
DNA methylation | Placental expression | Small fetus | Large fetus | Insulin growth factor | HUMAN PLACENTA | FACTOR-II | 5-METHYLCYTOSINE | GENE-EXPRESSION PATTERNS | FETUS | IMPRINTED GENES | HORMONE | MESSENGER-RNA | ONCOLOGY | GENETICS & HEREDITY | BINDING-PROTEIN 3 | IGF-II | Insulin-Like Growth Factor Binding Protein 3 - genetics | Insulin-Like Growth Factor Binding Proteins - physiology | Insulin-Like Growth Factor II - physiology | Humans | Fetal Growth Retardation - genetics | Insulin-Like Growth Factor I - genetics | Promoter Regions, Genetic - genetics | Case-Control Studies | DNA Methylation | Insulin-Like Growth Factor II - genetics | Fetal Growth Retardation - etiology | Adult | Female | Insulin-Like Growth Factor Binding Protein 4 - physiology | Insulin-Like Growth Factor Binding Protein 2 - physiology | Infant, Newborn | Insulin-Like Growth Factor Binding Protein 3 - physiology | Insulin-Like Growth Factor Binding Proteins - genetics | Insulin-Like Growth Factor Binding Protein 1 - physiology | Insulin-Like Growth Factor Binding Protein 4 - genetics | Insulin-Like Growth Factor Binding Protein 2 - genetics | Placenta - metabolism | Pregnancy | Insulin-Like Growth Factor I - physiology | Infant, Small for Gestational Age | Insulin-Like Growth Factor Binding Protein 1 - genetics | Infants (Newborn) | Epigenetic inheritance | RNA | Growth | Genes | Gene expression | Purines | Pyrimidines | Fetus | Binding proteins | Methylation | Protein binding
Journal Article